Related Experiment Video
Updated: Jul 1, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation
G-T Ho1,2, R E Aird1,3, B Liu4
1MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Abstract:
The multidrug resistance-1 (MDR1) gene encodes an ATP-dependent efflux transporter that is highly expressed in the colon. In mice, loss of MDR1 function results in colitis with similarities to human inflammatory bowel diseases (IBD). Here, we show that MDR1 has an unexpected protective role for the mitochondria where MDR1 deficiency results in mitochondrial dysfunction with increased mitochondrial reactive oxygen species (mROS) driving the development of colitis. Exogenous induction of mROS accelerates, while inhibition attenuates colitis in vivo; these effects are amplified in MDR1 deficiency. In human IBD, MDR1 is negatively correlated to SOD2 gene expression required for mROS detoxification. To provide direct evidential support, we deleted intestinal SOD2 gene in mice and showed an increased susceptibility to colitis. We exploited the genome-wide association data sets and found many (∼5%) of IBD susceptibility genes with direct roles in regulating mitochondria homeostasis. As MDR1 primarily protects against xenotoxins via its efflux function, our findings implicate a distinct mitochondrial toxin+genetic susceptibility interaction leading to mitochondrial dysfunction, a novel pathogenic mechanism that could offer many new therapeutic opportunities for IBD.
Insights
The multidrug resistance-1 (MDR1) gene protects mitochondria from damage, preventing colitis. MDR1 deficiency increases mitochondrial reactive oxygen species (mROS), driving inflammatory bowel disease (IBD) development.
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- The multidrug resistance-1 (MDR1) gene encodes an efflux transporter highly expressed in the colon.
- MDR1 deficiency in mice causes colitis, mimicking human inflammatory bowel diseases (IBD).
Purpose of the Study:
- To investigate the role of MDR1 in mitochondrial function and its connection to colitis development.
- To explore the link between MDR1, mitochondrial reactive oxygen species (mROS), and IBD pathogenesis.
Main Methods:
- Mice models with altered MDR1 and SOD2 gene expression were utilized.
- Mitochondrial function, mROS levels, and colitis development were assessed.
- Genome-wide association data for IBD susceptibility genes were analyzed.
Main Results:
- MDR1 deficiency leads to mitochondrial dysfunction and increased mROS, exacerbating colitis.
- Inhibition of mROS attenuated colitis, while induction accelerated it, especially in MDR1-deficient mice.
- Human IBD patients showed a negative correlation between MDR1 and SOD2 expression; SOD2 deletion increased colitis susceptibility in mice.
- A significant portion of IBD susceptibility genes are involved in mitochondrial homeostasis.
Conclusions:
- MDR1 plays a protective role in mitochondria, preventing colitis by limiting mROS.
- Mitochondrial dysfunction, driven by a combination of toxins and genetic susceptibility, represents a novel pathogenic mechanism in IBD.
- These findings suggest new therapeutic strategies targeting mitochondrial pathways for IBD treatment.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Related Concept Videos
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease